英国系统性硬化症当代流行病学:基于人群的队列研究
该研究利用英国初级保健数据库THIN(2000-2012年)纳入4,520,299人,经人工复核识别1321例系统性硬化症(SSc)患者,估算发病率为2.02/10万人年,患病率从17.13/10万升至25.38/10万,SSc患者调整后死亡率为一般人群的2.82倍。
要点
- SSc发病率女性(3.36/10万人年)明显高于男性(0.61/10万人年)。
- 研究期间SSc患病率上升,但发病率未同步增加。
- SSc患者调整后死亡率为一般人群的2.82倍(95%CI 2.55-3.13)。
核心结论
- THIN数据库可精确、有效地估算SSc的发生情况。
- 观察到的SSc患病率增加并非由发病率增加驱动。
研究设计与样本
- 基于英国THIN初级保健数据库的人群队列研究,纳入2000-2012年间4,520,299名1-99岁个体。
- 通过人工复核患者档案(含自由文本)验证SSc病例,并对100例样本使用问卷进行病例验证。
- 计算发病率、患病率和死亡率。
主要发现
- 共识别1321例SSc(689例新发,632例现患),平均随访7.6年,平均诊断年龄59.1岁。
- SSc发病率总体为2.02/10万人年(95%CI 1.87-2.17),女性为3.36(3.09-3.64),男性为0.61(0.49-0.74)。
- 不同日历年份发病率范围为1.53(1.11-2.06)至2.56(1.78-3.56)/10万人年。
- 患病率从17.13/10万(95%CI 14.97-19.51)增至25.38/10万(23.68-27.16),女性更高。
- SSc患者相对一般人群的调整死亡率比为2.82(95%CI 2.55-3.13)。
关键数值与推荐
- 人工复核后THIN中SSc诊断的阳性预测值为94%(基于91/100份有效问卷)。
临床怎么用
- THIN数据库可用于SSc的流行病学监测和研究。
- SSc患者死亡率显著高于一般人群,需加强疾病管理和随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the contemporary epidemiology of systemic sclerosis (SSc) in the UK and to explore the validity of using The Health Improvement Network (THIN) primary care database to study SSc. METHODS: 4,520,299 individuals (2000-2012) aged 1-99 years were followed to identify potential incident cases of SSc; potential prevalent cases were identified at start of follow-up. Patient profiles, including free-text comments, were manually reviewed to verify cases of SSc, and case validation was undertaken for a sample (n = 100) using questionnaires to primary care physicians. Incidence, prevalence and mortality rates were calculated. RESULTS: Following manual review, we identified 1321 cases of SSc (689 incident and 632 prevalent) over a mean follow-up of 7.6 years; mean age at diagnosis 59.1 years. Using information from 91/100 valid questionnaires returned, the positive predictive value of SSc diagnoses in THIN following manual review was 94%. Incidence rates of SSc per 100,000 person-years (95% CI) were 2.02 (1.87-2.17) overall, [3.36 (3.09-3.64) in females, 0.61 (0.49-0.74) in males], ranging from 1.53 (1.11-2.06) to 2.56 (1.78-3.56) across calendar years. Prevalence of SSc per 100,000 (95% CI) increased from 17.13 (14.97-19.51) to 25.38 (23.68-27.16) over the study period, and was higher in females. Using Poisson regression, the adjusted mortality rate ratio was 2.82 (95% CI: 2.55-3.13) among SSc cases versus the general population. CONCLUSIONS: THIN enables precise and valid estimates of SSc occurrence to be determined. The observed increase in SSc prevalence has not been driven by increasing incidence.
引用
- García Rodríguez LA, González-Pérez A, Michel A, et al. Contemporary epidemiology of systemic sclerosis: A population-based cohort study in the United Kingdom. Semin Arthritis Rheum. 2018. PMID: 30470546. doi:10.1016/j.semarthrit.2018.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。